MedTrace Logo

Study Evaluating Renal Cell Carcinoma Risk Factors

NCT00927043 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 145

Last updated 2011-11-07

No results posted yet for this study

Summary

This is an epidemiological, prospective, multicenter study designed to identify the pre-treatment clinical, molecular and genetic prognostic factors associated with progression free survival in patients naïve to renal cell carcinoma (RCC) treatment.

Conditions

  • Carcinoma, Renal Cell

Interventions

OTHER

Epidemiological study according to clinical practice

Epidemiological study according to clinical practice.

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00927043 on ClinicalTrials.gov